PubRank

H E Lehmann

Author PubWeight™ 33.94‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Yawning. A homeostatic reflex and its psychological significance. Bull Menninger Clin 1979 2.16
2 Adynamic ileus during psychoactive medication: a report of three fatal and five severe cases. Can Med Assoc J 1967 1.40
3 Dose equivalent for haloperidol and phenothiazines. Can Med Assoc J 1967 1.38
4 Side effects and teratogenicity of lithium carbonate treatment. J Clin Pharmacol J New Drugs 1970 1.12
5 Toxic psychotic syndrome associated with chlorpromazine administration. Can Med Assoc J 1970 1.07
6 Chemical reduction of the compulsion to drink with metronidazole: a new treatment modality in the therapeutic program of the alcoholic. Curr Ther Res Clin Exp 1967 1.07
7 A clinical trial with nomifensin, a new antidepressant drug. Int J Clin Pharmacol Biopharm 1975 0.98
8 Beta-endorphin--induced changes in schizophrenic and depressed patients. Arch Gen Psychiatry 1977 0.91
9 The philosophy of long-acting medication in psychiatry. Dis Nerv Syst 1970 0.91
10 Metronidazole in the treatment of the alcoholic. Psychiatr Neurol (Basel) 1966 0.90
11 A comparison of the hypnotic properties of mandrax and its two constituents. Curr Ther Res Clin Exp 1968 0.90
12 Therapy of Phenothiazine-produced skin pigmentation: a preliminary report. Am J Psychiatry 1966 0.88
13 The effect of hypnotics on rapid eye movement (REM). Int Z Klin Pharmakol Ther Toxikol 1968 0.84
14 Systematic clinical studies with trazodone: methodological aspects. Curr Ther Res Clin Exp 1973 0.83
15 Effect of withdrawal of antiparkinsonian medication on chronically hospitalized psychiatric patients. Laval Med 1970 0.82
16 Neurological side effects of lithium: organic brain syndrome, seizures, extrapyramidal side effects, and EEG changes. Compr Psychiatry 1980 0.82
17 The future of psychiatry: progress--mutation--or self destruct? Can J Psychiatry 1986 0.81
18 Nicotinic acid in the treatment of schizophrenias. Canadian Mental Health Association collaborative study: progress report II. Can Psychiatr Assoc J 1975 0.81
19 Sexual behavior of the male schizophrenic: the impact of illness and medications. Arch Sex Behav 1981 0.80
20 Potentiation of therapeutic effects of nicotinic acid by pyridoxine in chronic schizophrenics. Can Psychiatr Assoc J 1973 0.78
21 Negative findings with megavitamins in schizophrenic patients: preliminary report. Commun Psychopharmacol 1977 0.78
22 Lack of indication for use of antiparkinson medication. A follow-up study. Dis Nerv Syst 1971 0.78
23 Problems of differential diagnosis and choice of therapy in depressive states. Psychosomatics 1965 0.77
24 Clinical evaluation and natural course of depression. J Clin Psychiatry 1983 0.77
25 Thiothixene and the thioxanthenes. Adv Biochem Psychopharmacol 1974 0.76
26 A survey of extrapyramidal manifestations in the inpatient population of a psychiatric hospital. Laval Med 1970 0.76
27 Acquired transient CNS hypersensitivity to lithium therapy. Can J Psychiatry 1980 0.76
28 Transmethylation hypothesis of schizophrenia: methionine and nicotinic acid. Int Pharmacopsychiatry 1977 0.76
29 A comparative evaluation of doxepin and chlordiazepoxide in the treatment of psychoneurotic outpatients. Curr Ther Res Clin Exp 1970 0.76
30 Pharmacotherapy of tension and anxiety. Curr Psychiatr Ther 1972 0.76
31 Nicotinic acid in the prevention and treatment of methionine-induced exacerbation of psychopathology in schizophrenics. Can Psychiatr Assoc J 1970 0.76
32 Comprehesiven clinical studies with thiothixene. Dis Nerv Syst 1975 0.76
33 Non-equivalence of anti-psychotic drugs. Can Med Assoc J 1968 0.75
34 Pimozide in the treatment of chronic schizophrenic patients. Curr Ther Res Clin Exp 1970 0.75
35 Nicotinic acid as adjuvant therapy in newly admitted schizophrenic patients. Can Med Assoc J 1970 0.75
36 Transference, discrimination and reversal. A comparison between normals and pathological groups. Cond Reflex 1973 0.75
37 Therapy-resistant depressions - a clinical classification. Pharmakopsychiatr Neuropsychopharmakol 1974 0.75
38 Agranulocytosis associated with methotrimeprazine (Nozinan) administration: a report of three cases. Can Med Assoc J 1970 0.75
39 Prospects in postgraduate education in psychiatry. Can Psychiatr Assoc J 1970 0.75
40 Affective disorders in the aged. Psychiatr Clin North Am 1982 0.75
41 Clinical studies with clopenthixol (sordinol) on chronic psychiatric patients. Curr Ther Res Clin Exp 1966 0.75
42 Comprehensive clinical studies with trazodone. Curr Ther Res Clin Exp 1973 0.75
43 Clinical perspectives on antidepressant therapy. Am J Psychiatry 1968 0.75
44 Proceedings: Introduction to the symposium on systematic studies with psychoactive drugs--new methods in the assessment of change. Psychopharmacol Bull 1976 0.75
45 [A comparative study of propericiazine in the management of antisocial behavior]. Union Med Can 1967 0.75
46 Treatment of chronic schizophrenic patients with haloperidol and chlorpromazine combined. Curr Ther Res Clin Exp 1968 0.75
47 Conditioning in the prediction of therapeutic outcome in depressions. Cond Reflex 1969 0.75
48 Efficacy of haloperidol in drug refractory patients. Int J Neuropsychiatry 1967 0.75
49 A double-blind, comparative clinical trial with ludiomil (CIBA 34,276-Ba) and amitriptyline in newly admitted depressed patients. Curr Ther Res Clin Exp 1973 0.75
50 Nicotinic acid, thioridazine, fluoxymesterone and their combinations in hospitalized geriatric patients: a systematic clinical study. Can Psychiatr Assoc J 1972 0.75
51 Introduction to the colloquium on new drugs in the treatment of schizophrenia. Psychopharmacol Bull 1977 0.75
52 Clinical observations with beta-endorphin injections. Psychopharmacol Bull 1978 0.75
53 A conditioning test battery for the study of psychopathological mechanisms and psychopharmacological effects. Can Psychiatr Assoc J 1970 0.75
54 A comparative study of molindone and trifluoperazine. Curr Ther Res Clin Exp 1970 0.75
55 New psychoactive drugs in psychogeriatrics. Psychopharmacol Bull 1976 0.75
56 Clomacran in the treatment of schizophrenic patients: a comparison of two assessment methods. Int J Clin Pharmacol Biopharm 1975 0.75
57 Anxiety: measurement and methodology: Findings with a conditionning test battery: differential responsiveness to diazepam and doxepin [proceedings]. Psychopharmacol Bull 1977 0.75
58 The differential effects of viloxazine and imipramine on performance tests: their relationship to behavioural toxicity. Psychopharmacol Bull 1980 0.75
59 A survey of extrapyramidal manifestations in patients attending an after care clinic of a psychiatric hospital. Laval Med 1970 0.75
60 An introduction to systematic studies. Psychopharmacol Bull 1976 0.75
61 The clinician's view of anxiety and depression. J Clin Psychiatry 1983 0.75
62 Conditioning in the prediction of drug withdrawal effects in chronic schizophrenic patients. Act Nerv Super (Praha) 1974 0.75
63 Proceedings: Butaclamol in the treatment of schizophrenia--a comparison of two treatment methods. Psychopharmacol Bull 1976 0.75
64 [Pigmentation of the skin: rare side effect, following the prolonged administration of high doses of chlorpromazine]. Ann Dermatol Syphiligr (Paris) 1966 0.75
65 Combined administration of thioridazine, nicotinic acid, and fluoxymesterone in the treatment of geriatric patients. Curr Ther Res Clin Exp 1971 0.75
66 Sex differences in long-term adverse effects of phenothiazines. Adv Biochem Psychopharmacol 1974 0.75
67 Nicotinic acid and catechol-O-methyl-transferase activity in schizophrenia. Int J Clin Pharmacol 1973 0.75
68 Discussion: a renaissance of psychiatric diagnosis? Am J Psychiatry 1969 0.75
69 ECDEU (BPRS) and AMP (PAS) studies compared transculturally. Psychopharmacol Bull 1975 0.75
70 [From Binet and Wundt to neuropsychological measurements and behavior scales]. Acta Psychiatr Belg 1983 0.75
71 The impact of scientific models on clinical psychopharmacology: a psychiatrist's view. Semin Psychiatry 1972 0.75
72 Psychotherapeutic profile of a new psychoactive drug trazodone (AF-1161). Int Pharmacopsychiatry 1975 0.75
73 Protrptyline in the treatment of chronic schizophrenic patients. Curr Ther Res Clin Exp 1970 0.75
74 Tolbutamide jundice associated with multiple drug therapy. Can Med Assoc J 1970 0.75
75 Psychopharmacological treatment of schizophrenia. Schizophr Bull 1975 0.75
76 A summary of systematic studies. Psychopharmacol Bull 1976 0.75
77 Doxepin and imipramine in the treatment of depression: a double-blind crossover clinical study with EKG recordings. Psychopharmacol Bull 1978 0.75
78 Psychopharmacological approaches to the organic brain syndrome. Compr Psychiatry 1983 0.75
79 Comparative pharmacotherapy of the aging psychotic patient. Laval Med 1967 0.75
80 Studies with new drugs in the treatment of convulsive disorders. Int Z Klin Pharmakol Ther Toxikol 1968 0.75
81 Doxepin in the treatment of psychoneurotic patients: a comparison between two clinical settings. Int Z Klin Pharmakol Ther Toxikol 1971 0.75
82 Classification of depressive states. Can Psychiatr Assoc J 1977 0.75
83 Experimental geriatrics. Selection and prediction of therapeutic responsiveness in geriatric patients. Can Psychiatr Assoc J 1968 0.75
84 A comparative study with pipothiazine palmitate and fluphenazine enanthate in the treatment of schizophrenic patients. Curr Ther Res Clin Exp 1975 0.75
85 A placebo-controlled clinical study with trazodone in schizophrenic patients. Psychopharmacol Bull 1977 0.75
86 Nicotinic acid in the treatment of schizophrenias. Can Psychiatr Assoc J 1970 0.75
87 Minimal maintenance medication: effects of three dose schedules on relapse rates and symptoms in chronic schizophrenic outpatients. Compr Psychiatry 1983 0.75
88 A preliminary investigation of WY-3263 versus amitriptyline in depressions. Curr Ther Res Clin Exp 1968 0.75
89 A standard- (trifluoperazine) controlled clinical study with clomacran in newly admitted schizophrenic patients. Psychopharmacol Bull 1977 0.75
90 A comparison of desipramine and amitriptyline plasma levels and therapeutic response. Psychopharmacol Bull 1978 0.75
91 Clinical studies with MO-1255, a new monoamine oxidase inhibitor antidepressant. Curr Ther Res Clin Exp 1966 0.75
92 Quantity control in psychiatry. Can Psychiatr Assoc J 1968 0.75
93 [The demonstration of alpha 1-fetoprotein in human tumor ascites and its partial purification]. Clin Chim Acta 1971 0.75
94 Psychopharmacology is a hybrid science. Int J Psychiatry 1967 0.75
95 Fluspirilene in the treatment of chronic schizophrenic patients. Curr Ther Res Clin Exp 1970 0.75
96 A trouble in the brain-mind: self-description of a depressive episode. Can J Psychiatry 1982 0.75
97 Adynamic ileus during psychoactive medication. Can Med Assoc J 1967 0.75
98 CI-601, a butyrophenone derivative, in the treatment of chronically withdrawn schizophrenic patients. Curr Ther Res Clin Exp 1970 0.75
99 Proceedings: Benzoctamine in the treatment of neurosis--an uncontrolled clinical study. Psychopharmacol Bull 1976 0.75
100 A clinical-pharmacological study with EXP 561. Curr Ther Res Clin Exp 1967 0.75
101 Colloquium on clinical trials with antidepressants--behavioral, psychophysical, and pharmacokinetic measurements: Introduction. Psychopharmacol Bull 1978 0.75
102 Viloxazine in the treatment of depression: psychophysical measures and clinical response. Psychopharmacol Bull 1978 0.75
103 Chemotherapy in aged psychiaric patients. Can Psychiatr Assoc J 1969 0.75
104 Uncontrolled study with pipothiazine palmitate. Int J Clin Pharmacol 1973 0.75
105 Conditioning and the classification of the chronic schizophrenic patient. Pavlov J Biol Sci 1980 0.75
106 Pharmacotherapy of schizophrenia. Proc Annu Meet Am Psychopathol Assoc 1966 0.75
107 Conditional reflex studies in the schizophrenias. Laval Med 1971 0.75
108 An adverse reaction unit: results and functions. Am J Psychiatry 1971 0.75
109 Pentylenetetrazol in the treatment of geriatric patients with disturbed memory function. J Clin Pharmacol New Drugs 1971 0.75
110 Differential effects of trazodone in depressed, schizophrenic and geriatric patients. Int J Clin Pharmacol 1974 0.75
111 Nomifensin in the treatment of depression: a report on the Canadian part of a transcultural study. Psychopharmacol Bull 1978 0.75
112 Behavioural reactions to triazolam. Lancet 1979 0.75
113 Troxonium tosylate in drug-induced Parkinsonism: a controlled comparative study. J Clin Pharmacol New Drugs 1971 0.75
114 [Preliminary report on the therapeutic action of flagyl in alcoholism]. Union Med Can 1966 0.75
115 An uncontrolled study with thiopropazate in the treatment of persistent dyskinesia. Psychopharmacol Bull 1977 0.75
116 Neuroleptic drugs and sexual function in schizophrenia. Mod Probl Pharmacopsychiatry 1980 0.75
117 An uncontrolled clinical study with EX 11-582A in the treatment of chronic schizophrenic patients. Psychopharmacol Bull 1977 0.75
118 A double-blind comparative clinical trial with maprotiline (Ludiomil) and imipramine in newly-admitted depressed patients. Curr Ther Res Clin Exp 1976 0.75
119 Treatment of depression with dexedrine and demerol. Curr Ther Res Clin Exp 1971 0.75
120 Is psychiatry approaching a steady state? Compr Psychiatry 1981 0.75
121 Diphosphopyridine nucleotide in the treatment of schizophrenia. JAMA 1967 0.75
122 Systematic studies with trimipramine--a new antidepressive drug. Can Psychiatr Assoc J 1967 0.75
123 An uncontrolled clinical trial carried out in Panama City, Panama. Psychopharmacol Bull 1976 0.75
124 Ascorbic acid levels in chronic psychotic patients. Psychopharmacol Commun 1975 0.75
125 CNS stimulants and anabolic substances in geropsychiatric therapy. Psychopharmacol Bull 1975 0.75
126 The use of methyldopa in schizophrenia: a review and comparative study. Am J Psychiatry 1972 0.75
127 Troxonium tosylate in the treatment of drug-induced extrapyramidal manifestations. Int Z Klin Pharmakol Ther Toxikol 1971 0.75
128 A standard- (trifluoperazine) controlled clinical study with pimozide in the maintenance treatment of schizophrenic patients, I. Psychopharmacol Bull 1977 0.75
129 An uncontrolled in clinical trial carried out in Verdun, Quebec, Canada. Psychopharmacol Bull 1976 0.75
130 An uncontrolled clinical study with piperacetazine in the maintenance treatment of chronic schizophrenic patients. Psychopharmacol Bull 1977 0.75
131 A transcultural study with clomacran: comparison of two assessment methods. Curr Ther Res Clin Exp 1974 0.75
132 [Isolation of homologous Australia antigen antibodies through immunoadsorption]. Klin Wochenschr 1971 0.75
133 Psychometric tests in evaluation of brain pathology, response to drugs. Geriatrics 1970 0.75
134 Human gastric antigens. I. The purification and preliminary characterization of the antigenic, acid-stable carboxyl esterase VI A. Eur J Clin Invest 1972 0.75
135 Clinical evaluation of a new psychotropic drug--molindone. Int Z Klin Pharmakol Ther Toxikol 1970 0.75
136 A comparative study of salivation in affective disorders. Psychiatr Clin (Basel) 1980 0.75
137 Psychological tests: practice effect in geriatric patients. Geriatrics 1968 0.75
138 A review of nicotinic acid, N-methylated indoleamines and schizophrenia. Int Pharmacopsychiatry 1978 0.75
139 Combined administration of thioridazine and nicotinic acid in the treatment of geriatric patients. Curr Ther Res Clin Exp 1971 0.75
140 Early organiform impairment test (OFIT). A new performance test for assessment of early cognitive impairment. Prog Neuropsychopharmacol Biol Psychiatry 1985 0.75
141 Proceedings: Thyrotropin releasing hormone in depression: clinical and endocrinological findings. Psychopharmacol Bull 1976 0.75
142 Boon for average, bane for excellence. Int J Psychiatry 1971 0.75
143 Myths, theories and treatment of schizophrenia. Dis Nerv Syst 1977 0.75
144 On the phenomenology of the depressive illnesses. Can Psychiatr Assoc J 1966 0.75
145 The effect of psychostimulants on psychometric test performance with special reference to conflict avoidance behavior. Curr Ther Res Clin Exp 1970 0.75
146 Doxepin in the treatment of hospitalized and ambulatory psychoneurotic patients. Int J Clin Pharmacol 1972 0.75
147 Combined administration of thioridazine and fluoxymesterone in the treatment of geriatric patients. Curr Ther Res Clin Exp 1970 0.75
148 The persistence of ambiguity. Int J Psychiatry 1971 0.75
149 Butaclamol in the treatment of schizophrenia. A standard-controlled clinical trial. Int Pharmacopsychiatry 1978 0.75
150 Doxepin in the treatment of hospitalized and ambulatory psychoneurotic patients. Int Z Klin Pharmakol Ther Toxikol 1972 0.75
151 Uses and abuses of psychoactive drugs. South Med J 1978 0.75
152 The place of thiothixene in the treatment of schizophrenic patients. A systematic clinical study. Can Psychiatr Assoc J 1970 0.75
153 Thiothixene. Its range of therapeutic activity. Int Z Klin Pharmakol Ther Toxikol 1970 0.75
154 Urinary incontinence associated with thioridazine administration. Can Med Assoc J 1971 0.75
155 R--806--03--01 in the treatment of depression: plasma levels and therapeutic response. Psychopharmacol Bull 1978 0.75
156 Propericiazine in psychiatric emergencies. A controlled comparative study. Can Psychiatr Assoc J 1972 0.75
157 A standard-controlled clinical study with benzquinamide in the treatment of chronic schizophrenic patients. Psychopharmacol Bull 1977 0.75
158 The nature and frequency fo the suicide syndrome, twenty years ago and today, in the english-speaking community of the province of Québec. Laval Med 1967 0.75
159 [Chromatographic studies on Australia antigen]. Verh Dtsch Ges Inn Med 1971 0.75
160 Conditional reflex studies in depression. Can Psychiatr Assoc J 1966 0.75
161 Depression: the evolution of modern paradigms and concepts. Clin Neuropharmacol 1986 0.75
162 Effects of psychoactive drugs on conflict avoidance behavior in human subjects. Act Nerv Super (Praha) 1971 0.75
163 WIN 27,147-2 in the treatment of depression. An uncontrolled clinical study. Int Pharmacopsychiatry 1977 0.75
164 A standard-controlled clinical study with trazodone in schizophrenic patients. Psychopharmacol Bull 1977 0.75
165 [Medical applications of hallucinogens]. Laval Med 1969 0.75
166 Test-retest performance in chronic schizophrenia on the Verdun Conditioning Program. Can Psychiatr Assoc J 1972 0.75
167 The emotional basis of illness. Dis Nerv Syst 1967 0.75
168 Proceedings: Systematic clinical studies with clomipramine in depressed psychiatric patients--IV. A summary report. Psychopharmacol Bull 1976 0.75
169 Fluphenazine enanthate in the treatment of chronic psychotic patients: a controlled clinical study. Int Z Klin Pharmakol Ther Toxikol 1971 0.75
170 [A special flicker fusion frequency method for detection of the effects of gerontopharmaceuticals exemplified by the L-eburnamonine study]. Psychiatr Neurol Med Psychol (Leipz) 1985 0.75
171 The impact of modern pharmacotherapy on the prognosis of psychiatric patients. Trans Assoc Life Insur Med Dir Am 1970 0.75
172 The effectiveness of combined phenothiazine and butyrophenone treatment in chronic schizophrenic patients. Curr Ther Res Clin Exp 1967 0.75
173 Empathy and perspective on consensus and automation? Implications of the new deal in psychiatric diagnosis. Compr Psychiatry 1967 0.75
174 Mesoridazine in acute psychotic disturbances. Curr Ther Res Clin Exp 1967 0.75
175 Multiple personality in a case of functional psychosis. Compr Psychiatry 1985 0.75
176 A call to arms for clinical research in Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry 1986 0.75
177 A clinical trial of thiothixene (Navane) in schizophrenics. Curr Ther Res Clin Exp 1967 0.75